BSX.PRA
Calamos Advisors’s Boston Scientific Corporation 5.50% Mandatory Convertible Preferred Stock, Series A BSX.PRA Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-322,682
| Closed | -$39.1M | – | 1130 |
|
|
2023
Q1 | $39.1M | Sell |
322,682
-258
| -0.1% | -$31.2K | 0.19% | 130 |
|
|
2022
Q4 | $37.1M | Sell |
322,940
-76
| -0% | -$8.73K | 0.17% | 151 |
|
|
2022
Q3 | $32.7M | Sell |
323,016
-93,639
| -22% | -$9.48M | 0.15% | 166 |
|
|
2022
Q2 | $42.3M | Buy |
416,655
+31,039
| +8% | +$3.15M | 0.18% | 130 |
|
|
2022
Q1 | $44.9M | Sell |
385,616
-2,958
| -0.8% | -$344K | 0.17% | 140 |
|
|
2021
Q4 | $44.6M | Buy |
+388,574
| New | +$44.6M | 0.17% | 136 |
|
|
2021
Q1 | – | Sell |
-484,157
| Closed | -$53M | – | 945 |
|
|
2020
Q4 | $53M | Sell |
484,157
-69,082
| -12% | -$7.57M | 0.31% | 72 |
|
|
2020
Q3 | $61.9M | Sell |
553,239
-16,677
| -3% | -$1.87M | 0.4% | 46 |
|
|
2020
Q2 | $59.7M | Buy |
+569,916
| New | +$59.7M | 0.42% | 45 |
|